📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease. (2021)

First Author: Alexander JL

Attributed to: King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(21)00374-5

PubMed Identifier: 34653395

Publication URI: http://europepmc.org/abstract/MED/34653395

Type: Journal Article/Review

Volume: 6

Parent Publication: The lancet. Gastroenterology & hepatology

Issue: 12